Table 4 Bivariate analysis of TB Treatment outcome with Clinical characteristics of TB/HIV co-infected patients attended Public hospitals of Harar town, Eastern Ethiopia, 2018
Characteristics | Treatment outcome | P- value | COR (95%CI) | |
|---|---|---|---|---|
Successful Treatment | Unsuccessful Treatment | |||
Patient category | ||||
 New cases | 273 (88.1%) | 37 (11.9%) | 0.058 | 1.00 |
 Re treatment | 30 (76.9%) | 9 (23.1%) | 0.45 (0.20–1.03) | |
Types of TB | ||||
 SPP TB | 90 (81.1%) | 21 (18.9%) |  | 1.00 |
 EP TB | 102 (85.7%) | 17 (14.3%) | 0.346 | 1.40 (0.70–2.82) |
 SNP TB | 111 (93.3%) | 8 (6.7%) | 0.007 | 3.24 (1.37–7.65) |
Functional status | ||||
 Working | 207 (88.5%) | 27 (11.5%) |  | 1.00 |
 Ambulatory | 92 (86.8%) | 14 (13.2%) | 0.662 | 0.86 (0.43–1.71) |
 Bedridden | 4 (44.4%) | 5 (55.6%) | 0.001 | 0.10 (0.03–0.41) |
WHO staging | ||||
 stage 1 | 72 (91.1%) | 7 (8.9%) |  | 1.00 |
 stage 2 | 94 (92.2%) | 8 (7.8%) | 0.806 | 1.14 (0.39–3.30) |
 stage 3 | 109 (85.2%) | 19 (14.8%) | 0.212 | 0.56 (0.22–1.39) |
 stage 4 | 28 (70.0%) | 12 (30.0%) | 0.005 | 0.23 (0.08–0.64) |
History of opportunistic infection | ||||
 No | 149 (93.7%) | 10 (6.3%) | 0.001 | 1.00 |
 Yes | 154 (81.1%) | 36 (18.9%) | 0.29 (0.14–0.60) | |
CPT initiated | ||||
 Yes | 264 (89.2%) | 32 (10.8%) | 0.003 | 1.00 |
 No | 39 (73.6%) | 14 (26.4%) | 0.34 (0.17–0.69) | |
CD4 count | ||||
  < 200 cells/μL | 83 (81.4%) | 19 (18.6%) |  | 1.00 |
 201–499 cells/μL | 155 (90.1%) | 17 (9.9%) | 0.041 | 2.09 (1.03–4.23) |
 ± 500 cells/μL | 65 (86.7%) | 10 (13.3%) | 0.349 | 1.49 (0.65–3.42) |
Duration on ART | ||||
  < 5 years | 199 (88.1%) | 27 (11.9%) | 0.357 | 1.00 |
  > 5 Years | 104 (84.6%) | 19 (15.4%) | 0.74 (0.39–1.39) | |